Skip to content
Screener

10x Genomics, Inc. TXG Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

TEC
Bio-TechneTECH
$68.32M-18.4%
Illumina logo
IlluminaILMN
$371M-9.5%
Quanterix Corporation logo
Quanterix CorporationQTRX
$15.86M-0.7%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
4.8%+0.7pp
Azenta logo
AzentaAZTA
$61.42M
Agilent Technologies logo
Agilent TechnologiesA

Other financials

Income statement

See full
Revenue$151.0M-12.6%
Gross profit$112.5M-10.1%
Operating income-$19.6M-165%
Net income-$17.9M-152%
EPS (diluted)-$0.14-150%

Balance sheet

See full
Cash & equivalents$502.5M+26.4%
Total debt$78.8M-9.2%
Total equity$825.5M+6.8%
Total assets$1.0B+5.1%

Cash flow

See full
Operating cash flow$17.0M-4.1%
CapEx$1.6M+0.6%
Free cash flow$15.4M-4.6%

Valuation

See full
Market cap$5.79B+271%
Enterprise value$5.37B+330%
P/S9.4×+7.0×

Profitability

See full
Gross margin70%+0.5pp
Operating margin-14.3%-1.1pp
Net margin-12.2%-0.8pp
FCF margin19.7%+10.9pp

Returns & leverage

See full
Return on equity-9.4%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.7×-0.1×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.

The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.

Filed
Aug 6, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054491
Line itemJune 30,2026December 31, 2025
Weighted-average remaining lease term6.3 years6.7 years
Weighted-average discount rate5.9%5.9%

Item 1. Financial Statements (Unaudited)

FAQ

What is 10x Genomics, Inc.'s operating lease ROU assets?
10x Genomics, Inc. (TXG) reported operating lease ROU assets of 5.9% in Q2 2026.
How has 10x Genomics, Inc.'s operating lease ROU assets changed year-over-year?
10x Genomics, Inc.'s operating lease ROU assets decreased by 0.0% year-over-year, from 5.9% to 5.9%.
What is the long-term trend for 10x Genomics, Inc.'s operating lease ROU assets?
Over 5 years (2020 to 2025), 10x Genomics, Inc.'s operating lease ROU assets has grown at a -98.3% compound annual growth rate (CAGR), from 4,698,300,000% to 5.9%.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about 10x Genomics, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude